Age is not an independent factor in cancer survival prices.

‘Other reasons given include the limited long-term benefits, weighed against younger patients, and the lack of financial, logistical and social support.’ The authors wish that their research will reduce the concentrate that other clinicians put on age if they treat older sufferers with cancer. ‘We would like to see less decisions taken based on age and more research that explores the complicated needs of older people, so that they can be treated more effectively and enjoy an improved standard of living’ concludes Dr Domingo.. Age is not an independent factor in cancer survival prices, but clinical trials exclude older patients Age group is not an independent element in cancer survival prices and should not impact decisions about how to take care of older patients, according to a study in the November problem of IJCP, the Independent Journal of Clinical Practice.Kaiser Health News, an editorially independent information service, is a program of the Kaiser Family members Foundation, a nonpartisan health care policy research corporation unaffiliated with Kaiser Permanente. Their retrospective overview of approximately 1,340 trauma patients, age groups 0 to 17 years, will be released in the Journal of Trauma and Acute Care Surgery and is currently on PubMed at Hematocrit is a bloodstream test that measures the %age of the quantity of whole blood that is made up of crimson blood cells. This measurement depends on the real number and size of red blood cells.